
The upgrade accelerates batch production while ensuring traceability and regulatory compliance, giving chemical, pharma, and food manufacturers faster time‑to‑market and lower engineering costs. It also strengthens Valmet’s position in the process‑automation market by bundling advanced batch control with its broader DCS ecosystem.
Batch processing remains a cornerstone for sectors such as chemicals, pharmaceuticals, and food, where product consistency and flexibility are paramount. Traditional ISA‑88 implementations required deep control‑system programming, creating bottlenecks for recipe engineers. Modern manufacturers therefore seek software that abstracts low‑level logic, allowing rapid recipe iteration while preserving strict traceability and auditability.
Valmet FlexBatch 8 answers that demand by marrying a web‑based, drag‑and‑drop environment with full integration into Valmet DNAe and D3 distributed control systems. Operators can assemble phases, operations, and unit recipes visually, schedule batches, and monitor execution without writing code. Enhanced features—manual step acknowledgment, refined permission controls, and campaign optimization tools—drive higher throughput, while built‑in electronic record‑keeping satisfies FDA 21 CFR Part 11 and ISPE GAMP‑5 requirements, reducing compliance risk.
Strategically, the release expands Valmet’s automation portfolio, positioning the company as a one‑stop provider for end‑to‑end batch control. Existing FlexBatch users gain a seamless upgrade path, protecting prior investments and encouraging broader adoption across Valmet’s global customer base. As industries push toward faster product cycles and tighter regulatory scrutiny, solutions like FlexBatch 8 are likely to become a differentiator, influencing procurement decisions and shaping the future of batch‑centric manufacturing.
Comments
Want to join the conversation?
Loading comments...